ADIM
CGNX icon

Alpha DNA Investment Management’s Cognex CGNX Stock Holding History

Alpha DNA Investment Management’s Portfolio CGNX Stock Details CGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-16,879
Closed -$1.42M – 112
2021
Q2 		$1.42M Buy
16,879
+8,792
+109% +$711K 0.97% 59
2021
Q1 		$670K Buy
8,087
+2,104
+35% +$175K 0.77% 45
2020
Q4 		$480K Buy
+5,983
New +$435K 0.51% 90

Other funds holding CGNX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Alpha DNA Investment Management's CGNX Position: Q3 2021 in Review

Alpha DNA Investment Management sold out of Cognex (CGNX) in Q3 2021, closing a stake of 16,879 shares — an estimated $1.42M sold.

Alpha DNA Investment Management first reported a position in CGNX in Q4 2020 and held it in 3 quarters. The position peaked at $1.42M in Q2 2021. 534 funds tracked by Wall St. Rank hold CGNX as of Q3 2021.

  • Alpha DNA Investment Management reported no remaining Cognex position as of Q3 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 16,879 Cognex shares in Q3 2021, an estimated $1.42M.
  • Alpha DNA Investment Management first reported a position in Cognex in Q4 2020 and held it in 3 quarters.
  • Alpha DNA Investment Management's Cognex position peaked at $1.42M in Q2 2021.
  • 534 funds tracked by Wall St. Rank held Cognex as of Q3 2021.

Based on Alpha DNA Investment Management's 13F filing for Q3 2021, filed 10 Nov 2021.